US Patent Issued to Novartis on July 1 for "Pharmaceutical combination comprising TNO155 and ribociclib" (Massachusetts, Delaware Inventors)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,343,344, issued on July 1, was assigned to Novartis AG (Basel, Switzerland).

"Pharmaceutical combination comprising TNO155 and ribociclib" was invented by Ying-Nan Pan Chen (Wilmington, Del.), Huaixiang Hao (Lexington, Mass.), Chen Liu (Wayland, Mass.) and Morvarid Mohseni (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pharmaceutical combination comprising TNO155 and ribociclib; pharmaceutical compositions comprising the same; and methods of using such combinations and compositions in the treatment or prevention of conditions in a SHP2 inhibitor combined with CDK4/6 inhibition is beneficial in, for example, the ...